| Ytd | 27.56% | |
| 1y | 22.06% |
| Open | 273.29 | Prev Close | 275.56 | Low | 273.55 | High | 279.60 | Mkt Cap | 1.42B |
| Vol | 22.51K | Avg Vol | 40.25K | EPS | 4.00 | P/E | 69.50 | Forward P/E | 21.49 |
| Beta | 0.75 | Short Ratio | 9.40 | Inst. Own | 39.61% | Dividend | 18.00 | Div Yield | 6.53 |
| Ex Div Date | 05-11 | Earning | 08-03 | 50-d Avg | 252.57 | 200-d Avg | 236.98 | 1yr Est | 190.00 |
SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Onco
Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Suc
PARAMUS, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that